Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02734758 · ClinicalTrials.gov registry record
Markers of Atrial Fibrillation
A clinical trial, sponsored by University of California, Davis.
- Completed
- Registry status
- 131
- Enrollment target
NCT02734758: Completed study, sponsored by University of California, Davis.
NCT02734758 is a clinical trial that has completed, run by University of California, Davis. The registered enrollment target is 131 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02734758 has completed, sponsored by University of California, Davis.
- COMPLETED
- Registry status
- 131 participants
- Enrollment target
Study Summary
This study will evaluate whether a gene marker can improve the identification of atrial fibrillation in patients with ischemic stroke, and evaluate whether the decision to anticoagulate could be improved by a marker of atrial fibrillation.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 131 participants |
| Start Date | 2011-08 |
| Est. Completion | 2020-10-01 |
What the finished NCT02734758 record still lists
NCT02734758 is an observational study that tracks outcomes without assigning an intervention. The registered 131 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT02734758 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02734758 about?
NCT02734758 is a clinical study titled "Markers of Atrial Fibrillation". This study will evaluate whether a gene marker can improve the identification of atrial fibrillation in patients with ischemic stroke, and evaluate whether the decision to anticoagulate could be improved by a marker of atrial fibrillation.
What is the current status of trial NCT02734758?
This trial is currently completed. The enrollment target is 131 participants. The study started on 2011-08. Estimated completion is 2020-10-01.
Who is sponsoring clinical trial NCT02734758?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03051464 · 131 participants · Phase 2
No Surgery Trial / Two Dose-escalation Strategies
- NCT04301843 · 131 participants · Phase 2
Eflornithine (DFMO) and Etoposide for Relapsed/Refractory Neuroblastoma
- NCT04748549 · 131 participants · NA
Intraoperative VR for Older Patients Undergoing TKA
- NCT05951179 · 131 participants · Phase 2
Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia